Warberg Asset Management »

Novabay Pharmaceuticals shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Novabay Pharmaceuticals (NBY) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.9k 10k 0.69

More positions owned by Warberg Asset Management

Invesco Qqq Tr Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Parsons Corp Del Note 0.250% 8/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Box Note 1/1 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Microsoft Corp Put Put Option
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Bloomin Brands Note 5.000% 5/0 (Principal)
Nrg Energy DBCV 2.750% 6/0 (Principal)

View all positions for Warberg Asset Management

Top funds holding Novabay Pharmaceuticals

Geode Capital Management
Virtu Financial
Warberg Asset Management
Tower Research Capital
Bank of America Corporation
Morgan Stanley
NVWM
Ronald Blue Trust
Royal Bank of Canada
Northwestern Mutual Wealth Management Company
Addison Advisors

View all funds holding Novabay Pharmaceuticals